> For the complete documentation index, see [llms.txt](https://rexis.gitbook.io/rexis/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://rexis.gitbook.io/rexis/data-level-secure-biomedical-sharing.md).

# Data Level: Secure Biomedical Sharing

### Data Level: Secure and Efficient Biomedical Data Sharing

Biomedical research—especially in areas such as genomics, precision medicine, and clinical trials—critically depends on large-scale, diverse datasets from multiple institutions (Berger et al., 2019).\
Yet effective data sharing among hospitals, universities, and industry partners is often hampered by:

* Heightened privacy risks
* Strict regulatory requirements (e.g., HIPAA, GDPR)
* Competitive and proprietary constraints (Nagaraj et al., 2020)

For example, genomic data can often be re-identified despite anonymization, creating serious privacy vulnerabilities that severely restrict data sharing and impede progress (Cho et al., 2022).

Common scenarios illustrate these barriers:

* **Multi-Institutional Clinical Studies**\
  Integrating patient records across institutions improves the robustness of clinical findings. However, privacy regulations frequently limit these exchanges, weakening collaboration and reproducibility (Berger et al., 2019).
* **Genomic Data Analysis**\
  Reluctance to share genomic datasets—due to re-identification risks—constrains large-scale studies essential for biomarker discovery and precision diagnostics (Cho et al., 2022).
* **Drug Discovery Collaborations**\
  Pharmaceutical companies and academic labs often withhold proprietary data (e.g., compound libraries, assay results) due to intellectual property concerns, slowing progress in translational research (Kim et al., 2021).

Several privacy-preserving computation methods have been proposed, but each exhibits key limitations when applied to biomedical data sharing:

* **Homomorphic Encryption (HE)** allows computation on encrypted data but imposes substantial computational overhead—particularly for nonlinear models (Gentry, 2009; Gilad-Bachrach et al., 2016).
* **Differential Privacy (DP)** protects individuals by injecting noise into results. However, this noise may degrade accuracy and diagnostic value (Abadi et al., 2016).
* **Secure Multi-party Computation (SMPC)** avoids raw data sharing but suffers from high communication costs, making it less scalable for applications like genome-wide studies or multi-site trials (Cho et al., 2022).

These limitations highlight the need for more **efficient, scalable, and privacy-preserving methods** to enable biomedical data sharing at population scale.

***

#### References

* Abadi, M., et al. (2016). Deep learning with differential privacy. *CCS*.
* Berger, B., et al. (2019). Federated learning in biomedical research.
* Cho, H., et al. (2022). Privacy-preserving genomic analysis. *Annual Review of Biomedical Data Science*.
* Gentry, C. (2009). Fully homomorphic encryption using ideal lattices. *STOC*.
* Gilad-Bachrach, R., et al. (2016). CryptoNets: Applying neural networks to encrypted data. *ICML*.
* Kim, M., et al. (2021). Privacy-preserving federated learning in medicine. *JAMIA*.
* Nagaraj, A., et al. (2020). Privacy constraints in clinical collaborations.